154 related articles for article (PubMed ID: 30811794)
1. Comparative case studies: PDAs treated with medication, surgical ligation, and transcatheter device closure.
Seaton R; Williams C; Peredo J
Congenit Heart Dis; 2019 Jan; 14(1):65-68. PubMed ID: 30811794
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results.
Gu X; Zhang Q; Sun H; Fei J; Zhang X; Kutryk MJ
Congenit Heart Dis; 2017 May; 12(3):289-293. PubMed ID: 27874259
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).
Kanabar K; Bootla D; Kaur N; Pruthvi CR; Krishnappa D; Santosh K; Guleria V; Rohit MK
Indian Heart J; 2020; 72(2):107-112. PubMed ID: 32534682
[TBL] [Abstract][Full Text] [Related]
4. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.
P S; Jose J; George OK
Indian Heart J; 2018; 70(2):308-315. PubMed ID: 29716712
[TBL] [Abstract][Full Text] [Related]
5. Overview of transcatheter patent ductus arteriosus closure in preterm infants.
Almeida-Jones M; Tang NY; Reddy A; Zahn E
Congenit Heart Dis; 2019 Jan; 14(1):60-64. PubMed ID: 30811790
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
7. Small residual patent ductus arteriosus after surgical ligation in young adult: to close or not to close - a dilemmatic case report.
Tondas AE; Mulawarman R; Trifitriana M; Guyanto M; Pranata R; Komaria
Pan Afr Med J; 2021; 38():219. PubMed ID: 34046125
[TBL] [Abstract][Full Text] [Related]
8. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous device closure of pediatirc patent ductus arteriosus through femoral artery guidance by transthoracic echocardiography without radiation and contrast agents.
Ye Z; Li Z; Yi H; Zhu Y; Sun Y; Li P; Ma N
J Cardiothorac Surg; 2020 May; 15(1):107. PubMed ID: 32448306
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter occlusion of the patent ductus arteriosus in premature infants weighing less than 1200 g.
Morville P; Douchin S; Bouvaist H; Dauphin C
Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F198-F201. PubMed ID: 29066474
[TBL] [Abstract][Full Text] [Related]
11. Is transcatheter closure superior to surgical ligation of patent ductus arteriosus among Nigerian Children?
Animasahun BA; Adekunle MO; Falase O; Gidado MT; Kusimo OY; Sanusi MO; Johnson A
Afr J Paediatr Surg; 2018; 15(2):100-103. PubMed ID: 31290473
[TBL] [Abstract][Full Text] [Related]
12. Patent Ductus Arteriosus closure in preterms less than 2kg: Surgery versus transcatheter.
Pamukcu O; Tuncay A; Narin N; Baykan A; Korkmaz L; Argun M; Ozyurt A; Sunkak S; Uzum K
Int J Cardiol; 2018 Jan; 250():110-115. PubMed ID: 29017778
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
14. New Patent Ductus Arteriosus Closure Devices and Techniques.
Agrawal H; Waller BR; Surendan S; Sathanandam S
Interv Cardiol Clin; 2019 Jan; 8(1):23-32. PubMed ID: 30449419
[TBL] [Abstract][Full Text] [Related]
15. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
Malviya M; Ohlsson A; Shah S
Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
[TBL] [Abstract][Full Text] [Related]
16. The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience.
Bruckheimer E; Godfrey M; Dagan T; Levinzon M; Amir G; Birk E
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1097-101. PubMed ID: 24532416
[TBL] [Abstract][Full Text] [Related]
17. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device.
Philip R; Waller BR; Agrawal V; Wright D; Arevalo A; Zurakowski D; Sathanandam S
Catheter Cardiovasc Interv; 2016 Feb; 87(2):310-7. PubMed ID: 26525611
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children.
Kang SL; Morgan G; Forsey J; Tometzki A; Martin R
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1102-8. PubMed ID: 24403100
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter device closure of patent ductus arteriosus.
Sultan M; Ullah M; Sadiq N; Akhtar K; Akbar H
J Coll Physicians Surg Pak; 2014 Oct; 24(10):710-3. PubMed ID: 25327911
[TBL] [Abstract][Full Text] [Related]
20. Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?
Rodríguez Ogando A; Planelles Asensio I; de la Blanca ARS; Ballesteros Tejerizo F; Sánchez Luna M; Gil Jaurena JM; Medrano López C; Zunzunegui Martínez JL
Pediatr Cardiol; 2018 Feb; 39(2):398-410. PubMed ID: 29119215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
